APP and dementia: Our previous study showed that apicidin treatment could significantly increase the expression of ADAM10, improve the levels of the alpha‐site C‐terminal fragment (αCTF) of APP, and ultimately reduce the production of beta‐amyloid peptide 1–42 (Aβ42) in cultured cells; however, this effect was not observed in animal models of dementia.